Medicare Coverage Update: Medicare will reimburse a new osteoporosis screening test, biomechanical CT (BCT), starting Oct. 5, 2026, with retroactive coverage to Jan. 1, 2024—aimed at better fracture-risk assessment than bone mineral density alone. Drug Safety Alerts: The FDA recalled 11,460 bottles of chlorthalidone tablets due to failed dissolution specs, raising concerns about effectiveness; separate reports also flag blood pressure medication recalls and pharmacist warnings for common beta blockers/diuretics. Health Policy & Access: Pennsylvania lawmakers signaled support for pharmacy benefit manager reform to protect independent pharmacies, while the UK’s Medical Training Prioritisation Act shows early impact on specialty training recruitment. Precision Medicine & Pharma Moves: Malaysia’s first dedicated framework for advanced cancer coverage via a reinsurance treaty targets CAR-T, targeted therapies, and precision immunotherapy, including overseas treatment benefits; biotech updates include Recce Pharmaceuticals advancing diabetic foot infection gel into pivotal Phase 3 and NRx Pharmaceuticals expanding access for depression treatment with NRX-101 plus TMS. Care Delivery & Systems: Baptist Medical Center South in Alabama earned Level 1 trauma center status; OneDose and EPR Fireworks launched an EMS integration to improve medication documentation accuracy. Public Health & Ethics: A UK privacy watchdog confirmed a hospital worker was sacked after alleged misuse of Kate Middleton’s medical records for cash.